Skip to main content
    P

    Pelthos Therapeutics Inc. (PTHS)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • AMEX

    $7.11
    -0.33 (-4.44%)

    Market Cap: $29.24M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Pelthos Therapeutics Inc. (PTHS) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Pelthos Therapeutics are Plus Therapeutics (PSTV), Pliant Therapeutics (PLRX) and Grace Therapeutics (GRCE). By market cap, Pelthos Therapeutics ranks 9th of the 13 companies on this page; Gain Therapeutics (GANX) is the largest at $46.31M.

    Peer Comparison

    PTHS's ROIC of -95.4% is above the peer median of -170.5%, and its revenue growth of 0.0% is in line with the median. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Pelthos Therapeutics (PTHS)$29.24MN/A0.5x-199.5%-95.4%0.0%0.00%
    Plus Therapeutics Inc (PSTV)$26.64MN/A2.0x-230.2%-827.8%-2.9%0.00%
    Pliant Therapeutics Inc (PLRX)$43.21MN/AN/A0.0%N/A-100.0%0.00%
    Grace Therapeutics, Inc. (GRCE)$38.08MN/AN/A0.0%N/A0.0%0.00%
    Gain Therapeutics Inc (GANX)$46.31MN/AN/A0.0%-170.5%-100.0%0.00%
    Telomir Pharmaceuticals, Inc. Common Stock (TELO)$36.15MN/AN/A0.0%N/A0.0%0.00%
    Pasithea Therapeutics Corp (KTTA)$17.44MN/AN/A0.0%N/A1498.0%0.00%
    OS Therapies Incorporated (OSTX)$34.87MN/AN/A0.0%218.0%0.0%0.00%
    Quince Therapeutics, Inc. (QNCX)$32.27MN/AN/A0.0%N/A0.0%0.00%
    Transcode Therapeutics Inc (RNAZ)$22.35MN/AN/A0.0%-412.7%0.0%0.00%
    ProMIS Neurosciences Inc. (PMN)$29.60MN/AN/A0.0%N/A0.0%0.00%
    Immutep Ltd ADR (IMMP)$25.64MN/A2.2x0.0%N/A633.0%0.00%
    Serina Therapeutics Inc (SER)$36.93MN/A288.7x0.0%-109.4%154.9%0.00%
    Peer median$33.57MN/A2.2x0.0%-170.5%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Pelthos Therapeutics, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Plus Therapeutics Inc (PSTV)
    Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacturing...
    PSTV competitors
    Pliant Therapeutics Inc (PLRX)
    Pliant Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers, develops...
    PLRX competitors
    Grace Therapeutics, Inc. (GRCE)
    Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada.
    GRCE competitors
    Gain Therapeutics Inc (GANX)
    Gain Therapeutics, Inc., a developing biotechnology company, is dedicated to developing a variety of therapies to treat diseases caused by protein misfolding.
    GANX competitors
    Telomir Pharmaceuticals, Inc. Common Stock (TELO)
    Telomir Pharmaceuticals, Inc., a pre-clinical-stage pharmaceutical company, focuses on the development and commercialization of therapeutic treatment for human...
    TELO competitors
    Pasithea Therapeutics Corp (KTTA)
    Pasithea Therapeutics Corp. The company is headquartered in Miami Beach, Florida.
    KTTA competitors
    OS Therapies Incorporated (OSTX)
    OS Therapies Incorporated is a pioneering biopharmaceutical company committed to developing innovative treatments for unmet medical needs...
    OSTX competitors
    Quince Therapeutics, Inc. (QNCX)
    Quince Therapeutics, Inc., a biopharmaceutical company, is focused on advancing precision therapies for rare and debilitating diseases.
    Transcode Therapeutics Inc (RNAZ)
    TransCode Therapeutics, Inc., a biopharmaceutical company, is dedicated to the development and commercialization of drugs for the treatment of metastatic...
    RNAZ competitors
    ProMIS Neurosciences Inc. (PMN)
    ProMIS Neurosciences Inc. is a pioneering biotechnology company focused on the development of innovative therapeutic solutions for neurodegenerative diseases...
    PMN competitors
    Immutep Ltd ADR (IMMP)
    Immutep Limited, a biotechnology company, is dedicated to the research and development of pharmaceutical candidates.
    Serina Therapeutics Inc (SER)
    Serina Therapeutics Inc is a pioneering biotechnology company focused on developing innovative solutions for unmet medical needs in oncology and neurology...
    SER competitors

    Frequently Asked Questions About PTHS

    Who are Pelthos Therapeutics' main competitors?

    The companies most similar to Pelthos Therapeutics include Plus Therapeutics (PSTV), Pliant Therapeutics (PLRX), Grace Therapeutics (GRCE), Gain Therapeutics (GANX) and Telomir Pharmaceuticals, Inc. Common Stock (TELO), listed from the closest match.

    Who is Pelthos Therapeutics' biggest competitor?

    Gain Therapeutics (GANX) is the largest of the similar companies at $46.31M; Plus Therapeutics (PSTV) is the closest match by business profile, size, sector and industry.

    How does PTHS stock compare with its competitors?

    PTHS' P/S is 0.5x against a peer median of 2.2x; its net margin is -199.5% against a peer median of 0.0%.

    Which of Pelthos Therapeutics' competitors pays a higher dividend?

    Pelthos Therapeutics pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Pelthos Therapeutics bigger than its competitors?

    No. Pelthos Therapeutics is 9th by market cap among the 13 companies on this page; the largest is Gain Therapeutics (GANX) at $46.31M.